淀粉样变性-话题@MedSci

#淀粉样变性#

62篇内容 | 1226人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1434703, encodeId=f3d71434e03d1, content=<a href='/topic/show?id=940265920ab' target=_blank style='color:#2F92EE;'>#淀粉样变性#</a>, objectTitle=AJH：干细胞移植治疗 AL 淀粉样变性的血液学反应和存活率的预测因素：一项 25 年的纵向研究, objectType=article, longId=730509, objectId=81f3e30509eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81f3e30509eb, replyNumber=0, likeNumber=23, createdTime=2022-06-27, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81f3e30509eb, moduleTitle=AJH：干细胞移植治疗 AL 淀粉样变性的血液学反应和存活率的预测因素：一项 25 年的纵向研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81f3e30509eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1434702, encodeId=6f2e1434e023c, content=<a href='/topic/show?id=940265920ab' target=_blank style='color:#2F92EE;'>#淀粉样变性#</a>, objectTitle=FDA批准vutrisiran治疗成人遗传性转甲状腺素蛋白淀粉样变性伴多发性神经病（hATTR-PN），这是第5款siRNA药物, objectType=article, longId=729775, objectId=6f41e29775b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f41e29775b5, replyNumber=0, likeNumber=51, createdTime=2022-06-18, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f41e29775b5, moduleTitle=FDA批准vutrisiran治疗成人遗传性转甲状腺素蛋白淀粉样变性伴多发性神经病（hATTR-PN），这是第5款siRNA药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f41e29775b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1434701, encodeId=47e31434e0120, content=<a href='/topic/show?id=940265920ab' target=_blank style='color:#2F92EE;'>#淀粉样变性#</a>, objectTitle=Neurology：种族对血浆Aβ42/Aβ40、磷酸化牛磺酸和神经丝光预测脑淀粉样变性的影响, objectType=article, longId=728190, objectId=a6ebe281907f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6ebe281907f, replyNumber=0, likeNumber=39, createdTime=2022-05-31, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6ebe281907f, moduleTitle=Neurology：种族对血浆Aβ42/Aβ40、磷酸化牛磺酸和神经丝光预测脑淀粉样变性的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6ebe281907f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1434700, encodeId=ba8d1434e00ea, content=<a href='/topic/show?id=940265920ab' target=_blank style='color:#2F92EE;'>#淀粉样变性#</a>, objectTitle=淀粉样变性脑血管病的诊断要点，一篇文章全掌握！, objectType=article, longId=726671, objectId=9015e2667193, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9015e2667193, replyNumber=0, likeNumber=20, createdTime=2022-05-13, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9015e2667193, moduleTitle=淀粉样变性脑血管病的诊断要点，一篇文章全掌握！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9015e2667193)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1434699, encodeId=04c81434699c9, content=<a href='/topic/show?id=940265920ab' target=_blank style='color:#2F92EE;'>#淀粉样变性#</a>, objectTitle= BJH：达雷妥尤单抗、来那度胺和地塞米松在新诊断的与多发性骨髓瘤相关的全身性轻链淀粉样变性患者中的应用, objectType=article, longId=726507, objectId=868be26507ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=868be26507ef, replyNumber=0, likeNumber=46, createdTime=2022-05-11, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=868be26507ef, moduleTitle= BJH：达雷妥尤单抗、来那度胺和地塞米松在新诊断的与多发性骨髓瘤相关的全身性轻链淀粉样变性患者中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=868be26507ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1434698, encodeId=992a1434698cb, content=<a href='/topic/show?id=940265920ab' target=_blank style='color:#2F92EE;'>#淀粉样变性#</a>, objectTitle=J Dermatolog Treat：激光治疗原发性局部皮肤淀粉样变性的效果如何？, objectType=article, longId=723582, objectId=61c0e235820a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61c0e235820a, replyNumber=0, likeNumber=25, createdTime=2022-04-07, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61c0e235820a, moduleTitle=J Dermatolog Treat：激光治疗原发性局部皮肤淀粉样变性的效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61c0e235820a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1434697, encodeId=f9e2143469eb7, content=<a href='/topic/show?id=940265920ab' target=_blank style='color:#2F92EE;'>#淀粉样变性#</a>, objectTitle=Stroke：系统性淀粉样变性，和颅内出血有何关系？, objectType=article, longId=299063, objectId=1cc02990630a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cc02990630a, replyNumber=0, likeNumber=38, createdTime=2022-02-19, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cc02990630a, moduleTitle=Stroke：系统性淀粉样变性，和颅内出血有何关系？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1cc02990630a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1434696, encodeId=cf36143469669, content=<a href='/topic/show?id=940265920ab' target=_blank style='color:#2F92EE;'>#淀粉样变性#</a>, objectTitle=Neurology：β-淀粉样变性机制与阿尔茨海默病、路易体痴呆相关，后者共存局部性β-淀粉样蛋白和皮质萎缩相互作用, objectType=article, longId=294069, objectId=58f52940692a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58f52940692a, replyNumber=0, likeNumber=23, createdTime=2022-01-17, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58f52940692a, moduleTitle=Neurology：β-淀粉样变性机制与阿尔茨海默病、路易体痴呆相关，后者共存局部性β-淀粉样蛋白和皮质萎缩相互作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58f52940692a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1434695, encodeId=f8521434695cf, content=<a href='/topic/show?id=940265920ab' target=_blank style='color:#2F92EE;'>#淀粉样变性#</a>, objectTitle=Leukemia：浆细胞疾病家族史与 MGUS、多发性骨髓瘤和系统性 AL 淀粉样变性的生存率提高有关, objectType=article, longId=220763, objectId=d703220e63d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d703220e63d2, replyNumber=0, likeNumber=44, createdTime=2021-11-23, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d703220e63d2, moduleTitle=Leukemia：浆细胞疾病家族史与 MGUS、多发性骨髓瘤和系统性 AL 淀粉样变性的生存率提高有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d703220e63d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1434704, encodeId=05031434e04d4, content=<a href='/topic/show?id=940265920ab' target=_blank style='color:#2F92EE;'>#淀粉样变性#</a>, objectTitle=眼眶淀粉样变性影像诊断, objectType=article, longId=281366, objectId=d9d82813660f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9d82813660f, replyNumber=0, likeNumber=43, createdTime=2021-11-10, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9d82813660f, moduleTitle=眼眶淀粉样变性影像诊断, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9d82813660f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1434694, encodeId=298e143469431, content=<a href='/topic/show?id=940265920ab' target=_blank style='color:#2F92EE;'>#淀粉样变性#</a>, objectTitle=JAHA：神经激素阻断与甲状腺素运载蛋白心脏淀粉样变性患者生存率无关, objectType=article, longId=219773, objectId=a363219e736a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a363219e736a, replyNumber=0, likeNumber=40, createdTime=2021-11-05, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a363219e736a, moduleTitle=JAHA：神经激素阻断与甲状腺素运载蛋白心脏淀粉样变性患者生存率无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a363219e736a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1434693, encodeId=a19d143469323, content=<a href='/topic/show?id=940265920ab' target=_blank style='color:#2F92EE;'>#淀粉样变性#</a>, objectTitle=Rheumatology：强直性脊柱炎患者淀粉样变性的风险、预测因素和预后, objectType=article, longId=219095, objectId=2d48219095d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d48219095d4, replyNumber=0, likeNumber=31, createdTime=2021-10-24, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d48219095d4, moduleTitle=Rheumatology：强直性脊柱炎患者淀粉样变性的风险、预测因素和预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d48219095d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1434692, encodeId=e9e61434692ff, content=<a href='/topic/show?id=940265920ab' target=_blank style='color:#2F92EE;'>#淀粉样变性#</a>, objectTitle=NEJM：采用CRISPR-Cas9进行在体基因编辑治疗转甲状腺素蛋白淀粉样变性, objectType=article, longId=215474, objectId=cc6f2154e469, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc6f2154e469, replyNumber=0, likeNumber=45, createdTime=2021-08-10, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc6f2154e469, moduleTitle=NEJM：采用CRISPR-Cas9进行在体基因编辑治疗转甲状腺素蛋白淀粉样变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc6f2154e469)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1434691, encodeId=bfc3143469113, content=<a href='/topic/show?id=940265920ab' target=_blank style='color:#2F92EE;'>#淀粉样变性#</a>, objectTitle=NEJM：CRISPR-Cas9体内基因编辑治疗转甲状腺素蛋白淀粉样变性, objectType=article, longId=215363, objectId=58cb215363aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58cb215363aa, replyNumber=0, likeNumber=37, createdTime=2021-08-07, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58cb215363aa, moduleTitle=NEJM：CRISPR-Cas9体内基因编辑治疗转甲状腺素蛋白淀粉样变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58cb215363aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1434690, encodeId=2be11434690e3, content=<a href='/topic/show?id=940265920ab' target=_blank style='color:#2F92EE;'>#淀粉样变性#</a>, objectTitle=Birtamimab治疗Mayo IV期AL淀粉样变性，将进行验证性III期AFFIRM-AL研究, objectType=article, longId=206692, objectId=8638206692c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8638206692c1, replyNumber=0, likeNumber=26, createdTime=2021-02-04, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8638206692c1, moduleTitle=Birtamimab治疗Mayo IV期AL淀粉样变性，将进行验证性III期AFFIRM-AL研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8638206692c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1434689, encodeId=06d0143468986, content=<a href='/topic/show?id=940265920ab' target=_blank style='color:#2F92EE;'>#淀粉样变性#</a>, objectTitle=Lancet Neurol：Patisiran治疗遗传性转甲状腺素蛋白淀粉样变性长期效果及安全性研究, objectType=article, longId=203514, objectId=468e203514a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=468e203514a5, replyNumber=0, likeNumber=41, createdTime=2020-11-19, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=468e203514a5, moduleTitle=Lancet Neurol：Patisiran治疗遗传性转甲状腺素蛋白淀粉样变性长期效果及安全性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=468e203514a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1434688, encodeId=2077143468880, content=<a href='/topic/show?id=940265920ab' target=_blank style='color:#2F92EE;'>#淀粉样变性#</a>, objectTitle=辉瑞罕见病创新药维万心®在中国获批，助力转甲状腺素蛋白淀粉样变性心肌病治疗, objectType=article, longId=201889, objectId=bc0c20188974, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc0c20188974, replyNumber=0, likeNumber=0, createdTime=2020-10-11, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc0c20188974, moduleTitle=辉瑞罕见病创新药维万心®在中国获批，助力转甲状腺素蛋白淀粉样变性心肌病治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc0c20188974)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1434687, encodeId=fe18143468e37, content=<a href='/topic/show?id=940265920ab' target=_blank style='color:#2F92EE;'>#淀粉样变性#</a>, objectTitle=强生提交Darzalex皮下注射剂新适应症上市申请，治疗轻链淀粉样变性, objectType=article, longId=200589, objectId=14462005895e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14462005895e, replyNumber=0, likeNumber=40, createdTime=2020-09-13, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14462005895e, moduleTitle=强生提交Darzalex皮下注射剂新适应症上市申请，治疗轻链淀粉样变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14462005895e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1434686, encodeId=f00e143468610, content=<a href='/topic/show?id=940265920ab' target=_blank style='color:#2F92EE;'>#淀粉样变性#</a>, objectTitle=NEJM：悬雍垂淀粉样变性-病例报道, objectType=article, longId=198847, objectId=9d3019884e0c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d3019884e0c, replyNumber=0, likeNumber=30, createdTime=2020-08-07, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d3019884e0c, moduleTitle=NEJM：悬雍垂淀粉样变性-病例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d3019884e0c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1434685, encodeId=7720143468567, content=<a href='/topic/show?id=940265920ab' target=_blank style='color:#2F92EE;'>#淀粉样变性#</a>, objectTitle=病例报道|以腹水为首发表现的肝淀粉样变性, objectType=article, longId=198243, objectId=af1e19824322, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af1e19824322, replyNumber=0, likeNumber=0, createdTime=2020-07-30, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af1e19824322, moduleTitle=病例报道|以腹水为首发表现的肝淀粉样变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af1e19824322)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淀粉样变性

2020-05-29

zhouqu_8 (审核中...)

前往app查看评论内容

#淀粉样变性#

AJH：干细胞移植治疗 AL 淀粉样变性的血液学反应和存活率的预测因素：一项 25 年的纵向研究

2022-06-27

zhouqu_8 (审核中...)

前往app查看评论内容

#淀粉样变性#

FDA批准vutrisiran治疗成人遗传性转甲状腺素蛋白淀粉样变性伴多发性神经病（hATTR-PN），这是第5款siRNA药物

2022-06-18

zhouqu_8 (审核中...)

前往app查看评论内容

#淀粉样变性#

Neurology：种族对血浆Aβ42/Aβ40、磷酸化牛磺酸和神经丝光预测脑淀粉样变性的影响

2022-05-31

zhouqu_8 (审核中...)

前往app查看评论内容

#淀粉样变性#

淀粉样变性脑血管病的诊断要点，一篇文章全掌握！

2022-05-13

zhouqu_8 (审核中...)

前往app查看评论内容

#淀粉样变性#

BJH：达雷妥尤单抗、来那度胺和地塞米松在新诊断的与多发性骨髓瘤相关的全身性轻链淀粉样变性患者中的应用

2022-05-11

zhouqu_8 (审核中...)

前往app查看评论内容

#淀粉样变性#

J Dermatolog Treat：激光治疗原发性局部皮肤淀粉样变性的效果如何？

2022-04-07

zhouqu_8 (审核中...)

前往app查看评论内容

#淀粉样变性#

Stroke：系统性淀粉样变性，和颅内出血有何关系？

2022-02-19

zhouqu_8 (审核中...)

前往app查看评论内容

#淀粉样变性#

Neurology：β-淀粉样变性机制与阿尔茨海默病、路易体痴呆相关，后者共存局部性β-淀粉样蛋白和皮质萎缩相互作用

2022-01-17

zhouqu_8 (审核中...)

前往app查看评论内容

#淀粉样变性#

Leukemia：浆细胞疾病家族史与 MGUS、多发性骨髓瘤和系统性 AL 淀粉样变性的生存率提高有关

2021-11-23

zhouqu_8 (审核中...)

前往app查看评论内容

#淀粉样变性#

眼眶淀粉样变性影像诊断

2021-11-10

zhouqu_8 (审核中...)

前往app查看评论内容

#淀粉样变性#

JAHA：神经激素阻断与甲状腺素运载蛋白心脏淀粉样变性患者生存率无关

2021-11-05

zhouqu_8 (审核中...)

前往app查看评论内容

#淀粉样变性#

Rheumatology：强直性脊柱炎患者淀粉样变性的风险、预测因素和预后

2021-10-24

zhouqu_8 (审核中...)

前往app查看评论内容

#淀粉样变性#

NEJM：采用CRISPR-Cas9进行在体基因编辑治疗转甲状腺素蛋白淀粉样变性

2021-08-10

zhouqu_8 (审核中...)

前往app查看评论内容

#淀粉样变性#

NEJM：CRISPR-Cas9体内基因编辑治疗转甲状腺素蛋白淀粉样变性

2021-08-07

zhouqu_8 (审核中...)

前往app查看评论内容

#淀粉样变性#

Birtamimab治疗Mayo IV期AL淀粉样变性，将进行验证性III期AFFIRM-AL研究

2021-02-04

zhouqu_8 (审核中...)

前往app查看评论内容

#淀粉样变性#

Lancet Neurol：Patisiran治疗遗传性转甲状腺素蛋白淀粉样变性长期效果及安全性研究

2020-11-19

zhouqu_8 (审核中...)

前往app查看评论内容

#淀粉样变性#

辉瑞罕见病创新药维万心®在中国获批，助力转甲状腺素蛋白淀粉样变性心肌病治疗

2020-10-11

zhouqu_8 (审核中...)

前往app查看评论内容

#淀粉样变性#

强生提交Darzalex皮下注射剂新适应症上市申请，治疗轻链淀粉样变性

2020-09-13

zhouqu_8 (审核中...)

前往app查看评论内容

#淀粉样变性#

NEJM：悬雍垂淀粉样变性-病例报道

2020-08-07

zhouqu_8 (审核中...)

前往app查看评论内容

#淀粉样变性#

病例报道|以腹水为首发表现的肝淀粉样变性

2020-07-30

科室
- - 订阅+
  - 更多科室
工具
服务